From: Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action
Receptor/factor/enzyme | Full receptor/ factor/enzyme name | Interaction | Reference(s) |
---|---|---|---|
Caspases | |||
Caspase-1 | Cysteinyl aspartate protease 1 | Suppresses | Yndart Arias et al. 2023) |
Caspase 8 | Cysteinyl aspartate protease 8/9 | Agonizes | Massi et al. 2006) |
Caspase 9 | Cysteinyl aspartate protease 8/9 | Agonizes | Massi et al. 2006) |
Receptors | |||
PPARγ | Peroxisome proliferator-activated receptor gamma | Agonizes | O’Sullivan 2016) |
P2X7 | P2X7 | Modulates | Liu et al. 2020) |
ADORA2A | Adenosine A2A receptor | Modulates | Mecha et al. 2013) |
TNF-α | Tumor necrosis factor α | Decreases | Suryavanshi et al. 2022) |
NF-κB | Nuclear factor kappa B | Decreases | Chen et al. 2023) |
NLRP3 | Intracellular "NOD-like" receptor (NLR) proteins | Suppresses | |
TLR4 | Toll like receptor 4 | Decreases | Chen et al. 2023) |
G-protein-coupled receptors | |||
GPR 3 | G-protein-coupled receptor 3 | Inversely activates, activates | |
GPR 6 | G-protein-coupled receptor 6 | Inversely activates, activates | |
GPR 12 | G-protein-coupled receptor 12 | Inverse activates, activates | |
Interleukins | |||
IL-1β* | Interleukin-1β | Decreases | Suryavanshi et al. 2022) |
IL-6* | Interleukin-6 | Decreases | Suryavanshi et al. 2022) |
IL-8* | Interleukin-18 | Decreases | Suryavanshi et al. 2022) |
MAPK Pathway | |||
p38 MAPK pathway** | Mitogen activated protein kinase | Activates | Hwang et al. 2017) |
ERK1/2*** | Extracellular signal-regulated kinase | Activates | Vrechi et al. 2021) |
Reduces both potency and efficacy of endogenous and exogenous cannabinoids on ERK1/2-PLCβ3-dependent signaling | Interaction | Laprairie et al. 2015) |